Veyong Pharma attends EuroTier 2024 in Hannover, Germany

From November 12th to 15th, the four-day Hannover International Livestock Exhibition EuroTier was held in Germany. This is the world’s largest livestock exhibition. More than 2,000 exhibitors from 60 countries and about 120,000 professional visitors participated in this exhibition. Mr. Li Jianjie, general manager of Veyong Pharma, Wang Chunjiang, director of technical services, and business representatives of the international department attended the event.

In this exhibition, the company combined the overseas market environment and customer needs, and brought several products such as raw materials ivermectin, abamectin, tiamulin fumarate, eprinomectin , etc. to the exhibition hall. During the exhibition, new and old customers from Germany, the Netherlands, Senegal, Brazil, Argentina, Egypt, Saudi Arabia, Libya, New Zealand, Turkey, Syria, the Philippines, Pakistan, Afghanistan, Iraq and other countries were received. Veyong Pharma introduced the company’s comprehensive strength, core strategy and key products to customers in detail. Many exhibitors highly praised the Veyong brand and showed great interest in the products exhibited this time. They reached cooperation intentions for multiple products with new customers from Brazil, Turkey, Argentina and other countries on site, and also provided solutions for the product line extension of old customers. At the same time, the exhibitors also had an in-depth understanding of the current status of animal husbandry development, breeding categories, scale, breeding mode, main concerns and required products in the countries and regions where the visiting customers are located, laying the foundation for further in-depth cooperation.

The keyword of this exhibition is “innovation”. During the exhibition, the exhibitors fully understood the new situation and new trends in the global animal husbandry industry, laying a solid foundation for breakthroughs in product development and production of synthetic biology.

In the future, Veyong Pharma will continue to adhere to the internationalization strategy, go to the forefront of the global industry, capture the latest market information, realize the transformation of the traditional trade-oriented international business model to a deep service-oriented model, inject strong momentum into the company’s global market layout, and contribute to the sustainable and healthy development of the company’s business.